chiglitazar

Trade name: Bilessglu

Small moleculeexperimental

Chemistry & pharmacology

Loading structure…

SMILES

O=C(c1ccc(F)cc1)c1ccccc1N[C@@H](Cc1ccc(OCCn2c3ccccc3c3ccccc32)cc1)C(=O)O
Mol. weight
572.64 g/mol
Lipinski Ro5
2 violation(s)
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • chiglitazar
  • chiglitazar

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07303803Phase 2Jan 1, 2026Chipscreen Biosciences, Ltd., Jiao Tong University
NCT06773221N/AFeb 5, 2025Capital Medical University, Peking University
NCT06191328N/AJan 31, 2024Jiao Tong University
NCT06125587Phase 2/Phase 3 (Phase 3)Nov 30, 2023Shengjing Hospital
NCT06007014N/AOct 31, 2023Sun Yat-Sen University
NCT05681273Phase 1Feb 17, 2023Chipscreen Biosciences, Ltd., Fudan University
NCT05515458Phase 1Sep 30, 2022Chipscreen Biosciences, Ltd., Suzhou Medical College
NCT05515445Phase 1Sep 30, 2022Chipscreen Biosciences, Ltd., Suzhou Medical College
NCT05193916Phase 2Mar 21, 2022Chipscreen Biosciences, Ltd.
NCT04807348Phase 3May 17, 2021Chipscreen Biosciences, Ltd., Peking University
NCT02173457Phase 3Jun 1, 2014Chipscreen Biosciences, Ltd., Jiao Tong University
NCT02121717Phase 3May 1, 2014Chipscreen Biosciences, Ltd., Peking University
Showing 12 of 12 trials
Page 1 / 1

Organizations

Research & Development (8)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Chipscreen Biosciences, Ltd.For profit8732014
Jiao Tong UniversityAcademic/Hospital3232014
Peking UniversityAcademic/Hospital3022014
Suzhou Medical CollegeAcademic/Hospital2012022
Capital Medical UniversityAcademic/Hospital1112025
Fudan UniversityAcademic/Hospital1012023
Shengjing HospitalAcademic/Hospital1112023
Sun Yat-Sen UniversityAcademic/Hospital1112023
8 organizations
Page 1 / 1